Mucodrenol (Ambroxol Hydrochloride)

Ambroxol Hydrochloride acts on the respiratory tract to reduce mucus viscosity and improve clearance, making it useful in several bronchopulmonary conditions.

• Acute bronchitis: facilitates expectoration of thick sputum and eases cough.
• Chronic bronchitis: improves daily mucus clearance and reduces cough frequency.
• COPD exacerbations: assists in clearing airway secretions during flare‑ups.
• Asthma exacerbations: helps remove mucus plugs that can worsen airflow limitation.
• Respiratory infections: supports the body’s natural clearance mechanisms during viral or bacterial infections.

• Ambroxol stimulates the production of pulmonary surfactant, enhances ciliary beat frequency, and reduces the viscosity of bronchial secretions. By increasing surfactant levels, it improves the rheological properties of mucus, while heightened ciliary activity promotes more efficient transport of mucus toward the pharynx, facilitating expectoration and improving airway patency.

Adverse reactions to Ambroxol are generally mild but can vary in frequency and severity.

Common Side Effects

• Nausea: mild stomach upset reported in some users.
• Vomiting: occasional episodes, especially with higher doses.
• Dyspepsia: discomfort or burning sensation in the upper abdomen.
• Taste disturbance: a transient bitter or metallic taste.
• Headache: mild to moderate intensity.
• Skin rash: mild erythematous eruption.

Serious or Rare Side Effects

• Anaphylactic reaction: sudden onset of swelling, difficulty breathing, or hives.
• Stevens‑Johnson syndrome: severe skin blistering and mucosal involvement.
• Hepatic enzyme elevation: abnormal liver function tests.
• Blood dyscrasias: rare cases of leukopenia or thrombocytopenia.
• Bronchospasm: paradoxical tightening of airway muscles.
• Angioedema: swelling of lips, tongue, or face.

When using Ambroxol, certain safety considerations should be observed.

• Pregnancy: consult a healthcare professional; safety data are limited.
• Breastfeeding: use with caution; monitor infant for any adverse effects.
• Renal impairment: dose adjustment may be required in severe kidney dysfunction.
• Asthma: monitor for possible bronchospasm, especially in severe disease.
• Drug interactions: review concomitant medications for potential interactions.
• Store at room temperature: keep in the original packaging, protect from moisture and direct heat.

Ambroxol may interact with other medicines; awareness of the interaction level helps manage risk.

Major Interactions (Avoid)

• Anticholinergic agents: may diminish mucociliary clearance benefits.
• Cytotoxic chemotherapy: potential increase in pulmonary toxicity.

Moderate Interactions (Monitor Closely)

• Beta‑2 agonists: additive bronchodilator effect may require monitoring.
• Macrolide antibiotics: possible increase in gastrointestinal upset.
• Other mucolytics: overlapping mechanisms could enhance side‑effect profile.